MIM
ALPN

Monashee Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Monashee Investment Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52,546
Closed -$2.08M – 142
2024
Q1 		$2.08M Sell
52,546
-22,246
-30% -$656K 0.25% 65
2023
Q4 		$964K Buy
+74,792
New +$1.04M 0.17% 33
2022
Q4 		– Sell
-100,000
Closed -$720K – 70
2022
Q3 		$720K Buy
+100,000
New +$824K 0.27% 41
2021
Q2 		– Sell
-29,652
Closed -$107K – 488
2021
Q1 		$107K Hold
29,652
– – 0.02% 291
2020
Q4 		$76K Hold
29,652
– – 0.01% 271
2020
Q3 		$4K Buy
+29,652
New +$271K ﹤0.01% 173
2015
Q2 		– Hold
0
– – – 55

Monashee Investment Management's ALPN Position: Q2 2024 in Review

Monashee Investment Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 52,546 shares — an estimated $2.08M sold.

Monashee Investment Management first reported a position in ALPN in Q3 2020 and held it in 6 quarters. The position peaked at $2.08M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Monashee Investment Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Monashee Investment Management sold 52,546 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $2.08M.
  • Monashee Investment Management first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 6 quarters.
  • Monashee Investment Management's Alpine Immune Sciences Inc position peaked at $2.08M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.